Saltarella, I.; Desantis, V.; Melaccio, A.; Solimando, A.G.; Lamanuzzi, A.; Ria, R.; Storlazzi, C.T.; Mariggiò, M.A.; Vacca, A.; Frassanito, M.A.
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma. Cells 2020, 9, 167.
https://doi.org/10.3390/cells9010167
AMA Style
Saltarella I, Desantis V, Melaccio A, Solimando AG, Lamanuzzi A, Ria R, Storlazzi CT, Mariggiò MA, Vacca A, Frassanito MA.
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma. Cells. 2020; 9(1):167.
https://doi.org/10.3390/cells9010167
Chicago/Turabian Style
Saltarella, Ilaria, Vanessa Desantis, Assunta Melaccio, Antonio Giovanni Solimando, Aurelia Lamanuzzi, Roberto Ria, Clelia Tiziana Storlazzi, Maria Addolorata Mariggiò, Angelo Vacca, and Maria Antonia Frassanito.
2020. "Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma" Cells 9, no. 1: 167.
https://doi.org/10.3390/cells9010167
APA Style
Saltarella, I., Desantis, V., Melaccio, A., Solimando, A. G., Lamanuzzi, A., Ria, R., Storlazzi, C. T., Mariggiò, M. A., Vacca, A., & Frassanito, M. A.
(2020). Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma. Cells, 9(1), 167.
https://doi.org/10.3390/cells9010167